Trading Signals: ALXN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Tue. Jul. 20, 2021)(Alexion Pharmaceuticals Inc)
| ALXN latest price $127.1800 (0%) ($125.4750 - $128.4200) on Thu. Nov. 8, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.55% (three month average) | RSI | 50 | Latest Price | $127.1800(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ALXN advances 1.2% a day on average for past five trading days. | Weekly Trend | ALXN advances 2.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ALXN advance at 0% a week (0% probability) IBB(61%) XBI(53%) XLV(51%) QQQ(50%) IVW(48%) | Factors Impacting ALXN price | ALXN will decline at least -1.275% in a week (0% probabilities). TLT(-26%) VXX(-17%) UUP(-14%) VIXM(-13%) SHY(-12%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.275% (StdDev 2.55%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $124.72(1.97%) | 10 Day Moving Average | $120.12(5.88%) | 20 Day Moving Average | $121.24(4.9%) | To recent high | -8.5% | To recent low | 14.6% | Market Cap | $27.865b | | | | Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. |